Literature DB >> 8616840

Functional analysis of pRb2/p130 interaction with cyclins.

P P Claudio1, A De Luca, C M Howard, A Baldi, E J Firpo, A Koff, M G Paggi, A Giordano.   

Abstract

The retinoblastoma (Rb) family consists of the tumor suppressor pRb and related proteins p107 and pRb2/p130. Ectopic expression of pRb and p107 results in a growth arrest of sensitive cells in the G1 phase of the cell cycle. We demonstrated here that the growth-suppressive properties of pRb2/p130 were also specific for the G1 phase. The A-, E-, and D-type cyclins as well as transcription factor E2F1 and the E1A viral oncoprotein were able to rescue the pRb2/p130-mediated G1 growth arrest in SAOS-2 cells. The rescue with cyclins A and E correlated with their physical interaction with pRb2/p130, which surprisingly has been found to occur over all phases of the cell cycle. The phosphorylation status as well as the kinase activity associated with pRb2/p130 dramatically increased near the G1-S-phase transition. This suggests that, like the other Rb family members, pRb and p107, the phosphorylation of pRb2/p130 is controlled by the cell cycle machinery and that pRb2/p130 may indeed be another key G1-S-phase regulator.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616840

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Authors:  C Cinti; L Leoncini; A Nyongo; F Ferrari; S Lazzi; C Bellan; R Vatti; A Zamparelli; G Cevenini; G M Tosi; P P Claudio; N M Maraldi; P Tosi; A Giordano
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  G1 to S phase cell cycle transition in somatic and embryonic stem cells.

Authors:  Irina Neganova; Majlinda Lako
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

3.  Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism.

Authors:  Anton Chestukhin; Larisa Litovchick; Katherine Rudich; James A DeCaprio
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 4.  Cell cycle kinases as therapeutic targets for cancer.

Authors:  Silvia Lapenna; Antonio Giordano
Journal:  Nat Rev Drug Discov       Date:  2009-07       Impact factor: 84.694

5.  The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family proteins.

Authors:  J Zalvide; H Stubdal; J A DeCaprio
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB.

Authors:  G J Mulligan; J Wong; T Jacks
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen.

Authors:  H Stubdal; J Zalvide; K S Campbell; C Schweitzer; T M Roberts; J A DeCaprio
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

8.  Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus.

Authors:  T Nozoe; D Korenaga; S Itoh; M Futatsugi; Y Maehara
Journal:  J Cancer Res Clin Oncol       Date:  2002-11-26       Impact factor: 4.553

Review 9.  Transcriptional deregulation underlying the pathogenesis of small cell lung cancer.

Authors:  Dong-Wook Kim; Keun-Cheol Kim; Kee-Beom Kim; Colin T Dunn; Kwon-Sik Park
Journal:  Transl Lung Cancer Res       Date:  2018-02

10.  Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2.

Authors:  N Cueille; R Nougarede; F Mechali; M Philippe; C Bonne-Andrea
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.